ArticleSovremennye tekhnologii v meditsine2026
Bone Defect Regeneration Using Mesenchymal Stem Cells from Bichat's Fat Pad.
Article in Sovremennye tekhnologii v meditsine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials and Methods: The experimental study was carried out on male Wistar rats (n=120) aged 2 months, weighing 250-300 g. B-MSCs and the osteoblasts differentiated from them were used for the regeneration of rat mandibular bone defects formed by a round bur. In the control group, the defect was not filled, the defect was healing under the blood clot. The biopsy specimens were histologically examined on days 14, 30, and 90 after the injury formed. Results: The infiltration of the bone defect site by inflammatory cells was revealed for all study groups 14 days after the injury. The groups with cell administration showed the resorption of bone trabeculae (B-MSC and osteoblast groups) and a large number of capillaries (an osteoblast group). On day 30 after the injury, the preparations of the groups with cell administration demonstrated a large number of capillaries (B-MSC and osteoblast groups) and primitive bone trabeculae with osteoblasts (an osteoblast group). Active osteoclastic resorption and inflammatory infiltration were revealed in the control group. The groups with cell administration 90 days after the injury, in contrast to the control group, were found to have the formation of spongy mature bone tissue (B-MSC and osteoblast groups), the presence of bone mineralization and myeloid bone marrow (an osteoblast group) in the bone defect zone. It indicated high regenerative potential of the cells used when replacing a bone defect and the significant reduction of a regeneration period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.